Masters of deception: A review of herpesvirus immune evasion strategies

Immunology and Cell Biology

Volumn 74, Issue 6, 1996, Pages 513-522

  Davis Poynter, Nicholas J ^a   Farrell, Helen E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

herpesvirus; immune regulation; virus host interaction

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; COMPLEMENT; CYTOKINE; CYTOKINE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CELLULAR IMMUNITY; HERPES VIRUS; HUMAN; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; VIRUS INFECTION;

HERPES; HERPESVIRIDAE;

EID: 0029770508     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.84     Document Type: Review

References (85)

1. McGeoch DJ, Cook S, Dolan A, Jamieson FE, Telford EAR. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 1995; 247: 443-58.
2. Spriggs MK. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 1996; 14: 101-30.
3. McFadden G. Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. Austin: RG Landes, 1995.
4. Rother K, Till GO, eds. The complement system. Berlin: Springer-Verlag, 1988.
5. Hirsch RL. The complement system: its importance in the host response to viral infection. Microbiol. Rev. 1982; 46: 71-85.
6. Albrecht J-C, Nicholas J, Biller D et al. Primary structure of the herpesvirus saimiri genome. J. Virol. 1992; 66: 5047-58.
7. Albrecht J-C, Fleckenstein B. New member of the multigene family of complement control proteins in herpesvirus saimiri. J. Virol. 1992; 66: 3937-40.
8. Fujita T, Inoue T, Ogawa K, Iida K, Tamura N. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertase by dissociating C2a and Bb. J. Exp. Med. 1987; 166: 1221-8.
9. Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V. Cloning of decay accelerating factor suggests novel use of splicing to generate two proteins. Nature 1987; 325: 545-9.
10. Fodor WL, Rollins SA, Bianco-Caron S et al. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 1995; 69: 3889-92.
11. Mold C, Bradt BM, Nemerow GR, Cooper NR. Epstein-Barr virus regulates activation and processing of the third component pathway of complement. J. Exp. Med. 1988; 168: 949-69.
12. Albrecht J-C, Nicholas J, Cameron R, Newman C, Fleckenstein B, Honess RW. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 1992; 190: 527-30.
13. Rother RP, Rollins SA, Fodor WL et al. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J. Virol. 1994; 68: 730-7.
14. Isaacs SN, Dotwal GJ, Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl Acad. Sci. USA 1992; 89: 628-32.
15. Bielefeldt-Ohmann H, Babuik LA. Induction of receptors for complement and immunoglobulins by herpesviruses of various species. Virus Res. 1988; 9: 335-42.
16. Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB. Glycoprotein C of herpes simplex virus gI acts as a receptor for the C3b complement component on infected cells. Nature 1984; 309: 633-5.
17. Eisenberg RJ, Ponce de Leon M, Friedman HM et al. Complement component C3b binds directly to purified glycoprotein C of infected cells of herpes simplex viruses types 1 and 2. Microb. Pathog. 1987; 3: 423-35.
18. Huemer HP, Larcher C, van Drunen Littel-van den Hurk S, Babuik LA. Species selective interaction of alphaherpesvirinae with the "unspecific" immune system of the host. Arch. Virol. 1993; 130: 353-64.
19. Huemer HP, Wang Y, Garred P, Koistinen V, Oppermann S. Herpes simplex virus glycoprotein C: Molecular mimicry of complement components by a viral protein. Immunology 1993; 79: 639-47.
20. Huemer HP, Larcher C, Coe NE. Pseudorabies glycoprotein III (gIII) derived from virions and infected cells binds to the third component of complement. Virus Res. 1992; 23: 271-6.
21. Hung SL, Srinivasan S, Friedman HM, Eisenberg RJ, Cohen GH. Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J. Virol. 1992; 66: 4013-27.
22. Hidaka Y, Sakai Y, Toh Y, Mori R. Glycoprotein C of herpes simplex virus type I is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J. Gen. Virol. 1991; 72: 915-21.
23. McNearny TA, Odell C, Holers VM, Spear PG, Atkinson JP. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralisation of viral infectivity. J. Exp. Med. 1987; 166: 1525-35.
24. Gerber SI, Belval BI, Herold BC. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 1995; 214: 29-39.
25. Harris SL, Frank I, Yee A, Cohen GH, Eisenberg RJ, Friedman HM. Glycoprotein gC of herpes simplex virus type 1 prevents complement mediated cell lysis and virus neutralisation. J. Infect. Dis. 1990; 162: 331-7.
26. Friedman HM, Wang L, Fishman NO et al. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J. Virol. 1996; 70: 4253-60.
27. Herold BC, WuDunn D, Soltys N, Spear PG. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 1991; 65: 1090-8.
28. Schreurs C, Mettenleiter TC, Zuckermann F, Sugg N, Ben-Porat T. Glycoprotein gIII of pseudorabies virus is multifunctional. J. Virol. 1988; 62: 2251-7.
29. Liang X, Babuik LA, van Drunen Littel-van den Hurk S, Fitzpatrick DR, Zamb TJ. Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII and gIV. J. Virol. 1991; 65: 1124-32.
30. Spear GT, Lurain NS, Parker CJ, Ghassemi M, Payne GH, Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. J. Immunol. 1995; 155: 4376-81.
31. Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J. Virol. 1988; 62: 1347-54.
32. Bell S, Cranage M, Borysiewicz L, Minson T. Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1. J. Virol. 1990; 64: 2181-6.
33. Dubin G, Frank I, Friedman HM. Herpes simplex type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J. Virol. 1990; 64: 2725-31.
34. Litwin V, Jackson W, Grose C. Receptor properties of two Varicella-zoster virus glycoproteins, gp I and gp IV, homologues to herpes simplex virus gE and gI. J. Virol. 1992; 66: 3643-51.
35. Dubin G, Basu S, Mallory DLP et al. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. J. Virol. 1994; 68: 2478-6.
36. Dowler KW, Veltri RW. In vitro neutralization of HSV-2: Inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). J. Med. Virol. 1984; 13: 251-9.
37. Frank I, Friedman HM. A novel function of the herpes simplex virus type I Fc receptor: Participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 1989; 63: 4479-88.
38. Dubin G, Socolof E, Frank I, Friedman HM. The herpes simplex virus type I Fc receptor protects infected cels from antibody dependent cellular cytotoxicity. J. Virol. 1991; 65: 7046-50.
39. Dingwell KS, Brunetti CR, Hendricks RL et al. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 1994; 68: 834-45.
40. Zsak L, Zuckerman F, Sugg N, Ben-Porat T. Glycoprotein I of pseudorabies virus promotes cell fusion and virus spread via indirect cell-cell transmission. J. Virol. 1992; 66: 2316-25.
41. Balan P, Davis-Poynter N, Bell S, Atkinson H, Browne H, Minson, T. An analysis of the in vitro and in vivo phenotypes of mutants of HSV-1 lacking glycoproteins gG, gE, gI or the putative gJ. J. Gen. Virol. 1994; 75: 1245-58.
42. Card JP, Whealy ME, Robbins AK, Enquist LW. Pseudorabies virus glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. J. Virol. 1992; 66: 3032-41.
43. Bin X, Tsugiya M, Ishida K, Furukawa T. Characterisation of IgG Fc receptors induced by human cytomegalovirus. J. Gen. Virol. 1989; 70: 893-900.
44. Yee C, Costa J, Hamilton V, Klein G, Rabson AS. Changes in the expression of Fc receptors produced by induction of Epstein-Barr virus in a lymphoma cell line. Virology 1982; 120: 376-82.
45. Thäle T, Lucin P, Schneider K, Eggers M and Koszinowski U. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 1994; 68: 7757-65.
46. Moore K, Vieira P, Fiorentino D, Trounstine M, Khan T, Mossmann T. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990; 248: 1230-4.
47. Vieira P, De Waal-Malefyt R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones by T and NK cells: Homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl Acad. Sci. USA 1991; 88: 1172-6.
48. Rode HJ, Bugert JJ, Handermann M et al. Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (the EcoRI DNA fragment N 4.2 kbp). Virus Genes 1994; 9: 61-75.
49. Telford EAR, Watson MW, Aird HA, Perry J, Davison AJ. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 1994; 249: 520-8.
50. Moore KW, O'Garra A, De Waal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu. Rev. Immunol. 1993; 11: 165-90.
51. Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991; 146: 3444-51.
52. Hsu DH, De Waal Malefyt R, Fiorentino DF et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250: 830-2.
53. Rousset F, Garcia E, Defrance T et al. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl Acad. Sci. USA 1992; 89: 1890-3.
54. Miyazaki I, Cheung RK, Dosch HM. Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 1993; 178: 439-47.
55. Swaminathan S, Hesselton R, Sullivan J, Kieff E. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J. Virol. 1993; 67: 7406-13.
56. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 1993; 150: 5445-56.
57. Yao Z, Fanslow WC, Seldin MF et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3: 811-21.
58. Yao Z, Painter SL, Fanslow FC et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 1995; 155: 5483-6.
59. Oppenheim JJ, Zacharie COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene intercrine cytokine family. Annu. Rev. Immunol. 1991; 9: 617-48.
60. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 1994; 12: 593-633.
61. Gayle RB, Sleath PR, Srinivasan S et al. Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J. Biol. Chem. 1993; 268: 7283-9.
62. Massung RF, Jayarama V, Moyer RW. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 1993; 197: 511-28.
63. Cao JX, Gershon PD, Black DN. Sequence analysis of HindIII Q2 fragment of capripox reveals a putative gene encoding a G protein-coupled chemokine receptor homologue. Virology 1995; 209: 207-12.
64. Nicholas J, Cameron KR, Honess RW. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 1992; 355: 362-5.
65. Ahuja SK, Murphy PM. Molecular piracy of mammalian interleukin 8 receptor type B by herpesvirus saimiri. J. Biol. Chem. 1993; 268: 20 691-4.
66. Neote K, Di Gregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression and signaling characteristics of a C-C chemokine. Cell 1993; 72: 415-25.
67. Gao JL, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 1994; 269: 28 539-42.
68. Chee MS, Satchwell SC, Freddie E, Weston KM, Barrell BG. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 1990; 344: 774-7.
69. Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 1996 (in press).
70. Gompels UA, Nicholas J, Lawrence G et al. The DNA sequence of human herpesvirus-6: structure, coding content and genome evolution. Virology 1995; 209: 29-51.
71. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol. 1996; 70: 5975-89.
72. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, Mocarski ES. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 1994; 68: 6243-53.
73. Browne H, Churcher M, Minson A. Identification, characterization and deletion analysis of HCMV gene products with homology to G protein-coupled receptors (abstract). The Seventeenth International Herpesvirus Workshop; 1992 August 1-7; Edinburgh. Edinburgh: Heriot-Watt University, 1992.
74. Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature 1991; 350: 203-5.
75. Yao Z, Maraskovsky E, Spriggs MK, Cohen JI, Armitage RJ, Alderson MR. Herpesvirus saimiri open reading frame 14, a protein encoded by a T-lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T-cell proliferation. J. Immunol. 1996; 156: 3260-6.
76. Li Z, Turk SM, Hutt-Fletcher LM. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 1995; 69: 3987-94.
77. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331: 269-72.
78. Browne H, Smith G, Beck S, Minson, T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 1990; 347: 770-1.
79. Fahnestock ML, Johnson JL, Renny Feldman RM, Neveu JM, Lane WS, Bjorkman PJ. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 1995; 3: 538-90.
80. Browne H, Churcher M, Minson T. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol. 1992; 66: 6784-7.
81. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 1995; 155: 5046.
82. Grundy JE, Shearer GM. The effect of cytomegalovirus infection on the host response to foreign and hapten-modified self-histocompatibilty antigens. Transplantation 1984; 37: 484-90.
83. Yokoyama WM. Natural killer cell receptors. Curr. Opinion Immunol. 1995; 7: 110-20.
84. Bancroft GJ, Shellam GR, Chalmer JE. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 1981; 126: 988-94.
85. Scalzo AA, Fitzgerald NA, Wallace CA et al. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 1992; 149: 581-9.